Lumos Pharma to Participate in World Orphan Drug Congress USA
AUSTIN, Texas, May 22, 2023 -- Lumos Pharma, Inc. , a biopharmaceutical company advancing an oral therapeutic candidate for idiopathic Pediatric Growth Hormone Deficiency through Phase 2 clinical... | May 22, 2023
Source: marketscreener.com